Word: walls
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
UNSCOM was set up in 1991 as part of the truce agreement to end the Gulf War. It had a simple mission: to verify the destruction of Saddam's remaining missile, chemical- and biological-weapons capability. But U.N. inspectors quickly hit a wall: Saddam had no intention of cooperating with their inspections. So, eager to do their jobs, they turned from monitoring to spying to uncover his hidden caches. In interviews with key intelligence and military officials, TIME has pieced together that slow slide into espionage--one that peaked last March when a specially trained operative from the Pentagon...
...Detroit is any indicator. Nearly a dozen automakers are unveiling new models or concept cars aimed at affluent buyers--the goal being to win a place on the open, prosperous highway of the American luxury-car market. Says Michael Dale, president of Jaguar North America: "The economy is wonderful, Wall Street is doing great, and people want to buy a car that feels like more than just transportation. Frankly, you're just not going to get that in a Firebird." John Smith, general manager of GM's Cadillac division, puts it another way: "Baby boomers have always been a relatively...
...truly was The End. The next challenge for the man Fortune estimates to have added $10 billion to the economy? Maintaining the brand that is Michael Jordan. Nike stock fell a couple of points on Jordan's announcement Tuesday before leveling off today. Time to start scoring points on Wall Street...
...could the same be done directly to cells within the human body? "That's where we hit the wall in the early 1990s," recalls Dr. James Wilson, director of the Institute for Human Gene Therapy at the University of Pennsylvania. One problem was that the body's immune system regarded the viral carriers as foreign invaders, and its response caused inflammation and swelling at the injection site. The antibodies that developed in response to the virus caused further difficulties. "In a very unfortunate turn of events," Wilson explains, "the patients would become immune against the therapy...
...seemed. "We banged our heads against the wall for 10 years," says Dr. Alan Oliff, head of cancer research at Merck. "We were on the verge of abandoning the project." Then Oliff's team realized something critical: the ras protein can't do its job until it has been activated by another enzyme called a farnesyl transferase. Maybe that would make a better target? Early word is that it does, but Merck won't publish the findings from its first human trials until sometime next year...